Search Results
Apr 28, 2026, 08:11 ET Prevent Blindness Debuts "Best Eyes for Life" National Multimedia Campaign as Survey Reveals Concerning Misconceptions on Eye Health
individual understands the importance of how eye and vision care today saves sight for tomorrow."Prevent Blindness Vice President, Marketing, Sarah R. Hecker explained, "A focal point of the 'Best Eyes for Life' campaign is to help people feel connected to their eye health and understand how it relates
More news about: Prevent Blindness
Apr 28, 2026, 08:03 ET New shares of Bioretec Ltd registered with the trade register
https://news.cision.com/bioretec/r/new-shares-of-bioretec-ltd-registered-with-the-trade-register,c4341303
More news about: Bioretec
Apr 28, 2026, 08:00 ET Luma Health Welcomes Eric Ingram as CFO; Luma's Operational AI Scales to Serve Half of United States in 2026
recent product release, R&D roadmap, and continued company growth support a mission to solve bottlenecks and missed steps across both front- and back-office workflows.About
More news about: Luma Health
Apr 28, 2026, 08:00 ET XTM International Appoints New CMO and VP of Engineering to Accelerate AI-Driven Growth
of delivering complex, concurrent strategic programmes on time, on budget and to specification. Sean will lead engineering execution across XTM's R&D function, including development, QA, support and architecture teams in Ireland and across XTM's global hubs."Great products
More news about: XTM International
Apr 28, 2026, 08:00 ET Symend and Walnut Launch SymendPrevent: Making Bill Payment Protection the New Standard to Prevent Churn in Essential Services
quality job — a 42-point collapse from 70% in mid-2022 (Gallup). 85% of Canadians now live paycheque to paycheque, up from 60% just a year ago (H&R Block). And in the UK, nearly four in five workers fear losing their job in 2026 (MyPerfectCV).Against that backdrop sits a protection
More news about: Symend
Apr 28, 2026, 08:00 ET Dermalogica Expands Professional Portfolio with Launch of PRO Pen Microneedling System
improvements in acne scarring, skin texture, and overall dermal quality across a wide range of skin types.In collaboration with Unilever R&D, we've developed a differentiated, clinically informed system designed to support skin regeneration, enhance dermal remodeling, and optimize outcomes.
More news about: Dermalogica
Apr 28, 2026, 08:00 ET Youlife Group Inc. Reports Full Year 2025 Financial Results
million for the year ended December 31, 2024, to RMB16.9 million (US$2.4 million) for the year ended December 31, 2025, primarily because we boosted R&D investment in innovative fields, such as industrial robotics.Operating income was RMB6.8 million (US$0.9 million) for the year
More news about: Youlife Group Inc.
Apr 28, 2026, 07:54 ET New shares of Bioretec Ltd registered with the trade register
https://news.cision.com/bioretec/r/new-shares-of-bioretec-ltd-registered-with-the-trade-register,c4341303
More news about: Bioretec
Apr 28, 2026, 07:37 ET Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework
for regional and global licensing, frontier technology incubation, and strategic collaboration in neurodegenerative diseasesJoint R&D aligned with China-UAE bilateral partnership and Abu Dhabi's Healthcare Life Sciences Vision 2030SHANGHAI,
More news about: Fosun Pharma
Apr 28, 2026, 07:17 ET Communiqué from Boliden's Annual General Meeting
https://news.cision.com/boliden/r/communique-from-boliden-s-annual-general-meeting,c4341157The following files are available for download:
More news about: Boliden
Apr 28, 2026, 07:13 ET Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue
https://news.cision.com/bioretec/r/bioretec-ltd-adjusts-the-terms-and-conditions-of-its-stock-option-programs-due-to-the-completed-righ,c4341328
More news about: Bioretec
Apr 28, 2026, 07:11 ET Niutech to Present Intelligent Continuous Pyrolysis Technology for European Circular Economy Closed-Loop at IFAT Munich 2026
waste types, environmental standards, investment models and end-use applications, Niutech continues to improve its integrated service system covering R&D, solution design, equipment manufacturing, project implementation and operational support, delivering more targeted solutions to global customers.
More news about: Niutech
Apr 28, 2026, 07:06 ET Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue
https://news.cision.com/bioretec/r/bioretec-ltd-adjusts-the-terms-and-conditions-of-its-stock-option-programs-due-to-the-completed-righ,c4341328
More news about: Bioretec
Apr 28, 2026, 07:03 ET CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea
gonorrhea is becoming increasingly complex due to rising antimicrobial resistance and limited treatment options," said Richard Alm, interim Chief of R&D at CARB-X. "AdJane's approach represents a technically grounded strategy that aims to address key challenges in generating protective immunity to reduce
More news about: AdJane
Apr 28, 2026, 07:02 ET Zentiva odwołuje się od decyzji TSUE w sprawie Dyrektywy dotyczącej oczyszczania ścieków komunalnych
fundamentalnych zasad prawnych UE.PRAGA i BRUKSELA, 28 kwietnia 2026 r. /PRNewswire/ -- Unijna dyrektywa dotycząca oczyszczania ścieków komunalnych (UWWTD) w dalszym ciągu budzi poważne obawy. Zentiva i inne przedsiębiorstwa
More news about: Zentiva Group a.s.
Apr 28, 2026, 07:00 ET Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai, China
integrated clinical-stage biopharmaceutical company developing inhaled therapeutics for pulmonary and systemic diseases, has opened its new satellite R&D facility in Shanghai, China. An opening ceremony was held on April 23, 2026, to inaugurate the site, with local Chinese authorities in attendance to
More news about: Transpire Bio
Apr 28, 2026, 07:00 ET Main Street Announces New Portfolio Investment
CorporationDwayne L. Hyzak, CEO, [email protected] R. Nelson, CFO, [email protected] 713-350-6000Dennard
More news about: Main Street Capital Corporation
Apr 28, 2026, 07:00 ET BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE
Dimerix Limited DMX-200 is a chemokine receptor (CCR2) antagonist administered to patients already receiving an angiotensin II type I receptor (AT1R) blocker, the standard of care treatment for hypertension and kidney disease. DMX-200 is protected by granted patents in various territories until 2032,
More news about: Dimerix
Apr 28, 2026, 07:00 ET Opera Reports First Quarter 2026 Results With Both Revenue and Adjusted EBITDA Exceeding High End of Guidance Ranges
versus the first quarter of 2025. During the quarter Opera added 4 million MAUs, with strong growth in PC browsers following the release of Opera One R3 with new built-in AI tools. Opera GX had 35 million average MAUs in the quarter across PC and mobile, up 1 million from the prior quarter.MiniPay
More news about: Opera Limited
Apr 28, 2026, 06:30 ET Hycroft Files First Quarter 2026 10-Q and Provides Corporate Update
(GDXJ) on March 20, 2026, and promoted from the MSCI Micro-Cap Index to the MSCI Small Cap Index both effective February 27, 2026Diane R. Garrett, President and Chief Executive Officer, commented: "The 2026 first quarter marked significant progress for the Company, highlighted by continued
More news about: Hycroft Mining Holding Corporation
Apr 28, 2026, 06:10 ET Bullen Ultrasonics Research and Early Innovation Manager Eric Norton to Speak at Ceramics Expo 2026 on Technology Transfer and Zero-Defect Manufacturing
technologies transition from laboratory innovation to commercial deployment, particularly in aerospace and defense applications. Speakers will examine common R&D, qualification and scalability barriers, along with strategies for de-risking pilot programs, structuring effective vendor partnerships and accelerating
More news about: Bullen Ultrasonics
Apr 28, 2026, 06:02 ET JCET Reports 42.7% YoY Surge in Q1 2026 Net Profit Attributable to Shareholders
the year.In parallel with capacity expansion, JCET continues to strengthen its R&D infrastructure and engineering capabilities in core technology domains. In the first quarter, the JCET Zhangjiang R&D Building in Shanghai officially commenced operations. Equipped with state-of-the-art facilities,
More news about: JCET Group
Apr 28, 2026, 06:00 ET Lighthouse Pharmaceuticals Closes $12 Million Series A Financing Led by Double Point Ventures
www.lighthousepharma.com.Research reported in this release is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG088524. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Media
More news about: Lighthouse Pharmaceuticals
Apr 28, 2026, 06:00 ET HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
global clinical leadership positions at Ferring Pharmaceuticals, Novartis Pharma and Novartis Institutes for Biomedical Research (NIBR), and Bayer R&D headquarters in Switzerland. His clinical expertise spans women's health, obesity and metabolic syndrome, osteoporosis, osteoarthritis, sarcopenia
More news about: HERVolution Therapeutics
Apr 28, 2026, 05:43 ET JCET Reports 42.7% YoY Surge in Q1 2026 Net Profit Attributable to Shareholders
the year.In parallel with capacity expansion, JCET continues to strengthen its R&D infrastructure and engineering capabilities in core technology domains. In the first quarter, the JCET Zhangjiang R&D Building in Shanghai officially commenced operations. Equipped with state-of-the-art facilities,
More news about: JCET Group